Your browser doesn't support javascript.
loading
Efficacy of targeted therapies for oncogene-driven lung cancer in early single-arm versus late phase randomized clinical trials: A comparative analysis.
Tan, Aaron C; Tan, Sze Huey; Zhou, Siqin; Peters, Solange; Curigliano, Giuseppe; Tan, Daniel S W.
Afiliación
  • Tan AC; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore. Electronic address: aaron.tan@singhealth.com.sg.
  • Tan SH; Duke-NUS Medical School, National University of Singapore, Singapore; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Zhou S; Division of Clinical Trials and Epidemiological Sciences, National Cancer Centre Singapore, Singapore.
  • Peters S; Oncology Department, University Hospital (CHUV), University of Lausanne, Lausanne, Switzerland.
  • Curigliano G; Division of Early Drug Development for Innovative Therapies, European Institute of Oncology (IEO), Scientific Institute for Research, Hospitalization and Healthcare (IRCCS), Milan, Italy; Department of Oncology and Haemato-Oncology, University of Milan, Milan, Italy.
  • Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Singapore; Duke-NUS Medical School, National University of Singapore, Singapore.
Cancer Treat Rev ; 104: 102354, 2022 Mar.
Article en En | MEDLINE | ID: mdl-35134620
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Cancer Treat Rev Año: 2022 Tipo del documento: Article